|  Nederlands |  English |
 
 
<Working on Health / Diseases / Neurology>
Neurology/Alzheimer's disease
The despairing cry from patients and families of patients with Alzheimer's disease (AD) is fast becoming a worldwide clamour as the ageing of populations continues to accelerate. By 2004, the over-75 age group in Europe, the USA and Japan is expected to exceed 51 million - an increase of 31% over a decade.
The prevalence of AD in subjects over 65 in these countries is currently estimated to be 7.5-9%, thrusting AD into the spotlight as a disease urgently requiring effective therapies to reduce the burden of human suffering. 		Fungal infections

Alzheimer's disease, a progressive form of dementia, is often associated with a group of symptoms which are evident as disturbances in behaviour. These symptoms often include severe agitation. In addition, deteriorating cognitive abilities make the sufferer increasingly dependent upon outside help and caregivers.

Click here to explore our R&D advances in this field.

 

Do you want to know more about our R&D commitment in this field?
Please explore the http://www.us.reminyl.com, a website which contains information on Alzheimer's disease, useful for patients, their family and care givers.

 
Diseases Overview
Fungal infections Mental Health
Allergies Neurology/Alzheimer's disease
Womens Health Pain
Cancer Gastro-intestinal Disorders
Biotechnology    
     
<< Back
 

 
 
© Janssen Pharmaceutica N.V., 1997-2010.

This site is published by Janssen Pharmaceutica NV and is intended for visitors from Europe. Use of the site constitutes your consent to application of European laws and regulations and to our Privacy Policy. Your use of the information on this site is subject to the terms of our Legal Notice.